Atrion (NASDAQ:ATRI) Now Covered by StockNews.com

Analysts at StockNews.com began coverage on shares of Atrion (NASDAQ:ATRIGet Free Report) in a report released on Tuesday. The firm set a “sell” rating on the medical instruments supplier’s stock.

Atrion Trading Up 0.2 %

Shares of Atrion stock opened at $453.90 on Tuesday. The company has a 50 day moving average of $452.56 and a 200-day moving average of $408.27. Atrion has a 1-year low of $274.98 and a 1-year high of $593.00. The company has a market cap of $798.86 million, a PE ratio of 42.66 and a beta of 0.68.

Atrion (NASDAQ:ATRIGet Free Report) last released its quarterly earnings data on Friday, May 10th. The medical instruments supplier reported $1.59 earnings per share (EPS) for the quarter. The business had revenue of $47.33 million during the quarter. Atrion had a net margin of 10.60% and a return on equity of 7.75%.

Hedge Funds Weigh In On Atrion

Several institutional investors and hedge funds have recently added to or reduced their stakes in ATRI. Penn Mutual Asset Management LLC acquired a new position in Atrion in the 4th quarter valued at approximately $1,949,000. Public Employees Retirement System of Ohio bought a new stake in shares of Atrion in the 1st quarter valued at $2,299,000. Citizens Financial Group Inc. RI bought a new stake in shares of Atrion in the 4th quarter valued at $1,114,000. Boston Trust Walden Corp boosted its stake in shares of Atrion by 4.8% in the 4th quarter. Boston Trust Walden Corp now owns 35,091 shares of the medical instruments supplier’s stock valued at $13,292,000 after purchasing an additional 1,609 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System bought a new stake in shares of Atrion in the 1st quarter valued at $421,000. 66.19% of the stock is currently owned by institutional investors and hedge funds.

Atrion Company Profile

(Get Free Report)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Featured Articles

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.